Developer docs
API playgroundTry for free, no card

Search company profiles

Sunshine Healthcare Lanka

Full company profile

uuid0002vw1

Namestring
Sunshine Healthcare Lanka
Legal namestring
Sunshine Healthcare Lanka Limited
Company typeenum
Private
Founded yearint
1967
Descriptiontext

Sunshine Healthcare Lanka Limited is the healthcare subsidiary of Sri Lankan conglomerate Sunshine Holdings PLC (Colombo Stock Exchange: SUN.N0000), operating a fully integrated pharmaceutical platform spanning importation, marketing, manufacturing, distribution, and retail. The company operates through four core business units: Healthguard Distribution, which provides island-wide pharmaceutical distribution serving over 4,500 healthcare retailers and hospitals through 7 Regional Distribution Centres covering 150 principal towns and 470 sub-towns; Lina Manufacturing, a WHO-GMP certified pharmaceutical manufacturer producing Sri Lanka's sole domestic Metered Dose Inhalers and related products under brands such as Beclovent, Flutivent, Salbuvent, Ventohaler, and Prazolin; Healthguard Pharmacy, a 13-outlet retail chain concentrated in the Western Province; and Sunshine Medical Devices, which distributes surgical, diagnostic, and imaging equipment from manufacturers including Siemens Healthineers, Johnson & Johnson, and GE Healthcare, supported by a 426-person sales and marketing team.

The technology backbone comprises the Lina Production System (LPS), a customised Lean Six Sigma framework with eight pillars covering quality, digital journey, and HSE; the iOrder application for client ordering; the IFS Enterprise Resource Planning system enabling real-time inventory traceability; and Sri Lanka's first Distribution-as-a-Service (DaaS) model branded as Project Infinity. The company represents more than 30 international pharmaceutical principals including Novo Nordisk, Abbott, Galderma, and Glenmark, and holds a 12% share of Sri Lanka's private pharmaceutical market.

Sunshine Healthcare generates revenue through multi-channel distribution (pharmaceutical distribution, medical devices, retail pharmacy sales, and government tender supply via SPC, Osu Sala, and the Ministry of Health), pharmaceutical manufacturing and contract development & manufacturing (CDMO) services for partners including Zydus Cadila, Mankind Pharma, and Kalbe International, and international pharmaceutical brand representation. The parent group reported LKR 65.9 billion in consolidated FY26 revenue with the Healthcare segment contributing 56.8% (approximately LKR 37.4 billion, ~USD 125 million). The IFC's October 2024 USD 10 million equity investment for a 14.73% stake implies a valuation of approximately USD 68 million for Sunshine Healthcare Lanka, and a 2026 joint venture with Zydus Lifesciences (Zydus Sunshine Lifesciences Pvt. Ltd., a 50:50 arrangement with combined investment exceeding USD 20 million) is adding new manufacturing capacity in Horana, Sri Lanka.

Short descriptiontext

Sunshine Healthcare Lanka is the healthcare subsidiary of Sunshine Holdings PLC, operating Sri Lanka's fully integrated pharmaceutical platform spanning manufacturing, importation, distribution, and retail, serving over 4,500 retailers and hospitals as the country's sole domestic MDI producer.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersColombo, Sri Lanka
HQ citystring
Colombo
HQ countrystring
Sri Lanka
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical distribution, pharmaceutical manufacturing, retail pharmacy services, medical devices distribution, contract pharmaceutical manufacturing
Industry4 codes
1OTC & Consumer Health Distributors
CodeHLAIAJACPrimaryYes
2Specialty Pharma & Biologics Distribution (GDP-compliant)
CodeHLAGAMADPrimaryNo
3Cold, Flu & Cough Remedies
CodeHLAIADABPrimaryNo
4Eye, Ear & Nasal Care
CodeHLAIADAFPrimaryNo
NAICS code2 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
  • Pharmaceutical Preparation Manufacturing325412
SIC code3 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Pharmaceutical Preparations2834
  • Retail-Drug Stores And Proprietary Stores5912
Product category
Pharmaceutical Distribution and Manufacturing
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Pharmaceutical Distribution
TypeTransaction Fee
Description

Distribution of prescription and OTC drugs representing over 50 international pharmaceutical companies. Second-largest private healthcare distribution company in Sri Lanka with 12% market share.

sunshineholdings.lk
2Pharmaceutical Manufacturing
TypeOne Time License
Description

Manufacturing of metered dose inhalers (MDIs) and contract development and manufacturing (CDMO) services. Sole manufacturer of MDIs in Sri Lanka with WHO-GMP certification.

sunshineholdings.lk
3Medical Devices Distribution
TypeTransaction Fee
Description

Distribution of surgical, diagnostic, and medical equipment from global manufacturers including Siemens Healthineers, Johnson & Johnson, GE Healthcare, and others.

sunshineholdings.lk
4Retail Pharmacy
TypeOthers
Description

Healthguard Pharmacies operates 13 retail outlets across Western Province offering pharmaceuticals, medical devices, wellness items, and consumer products.

sunshineholdings.lk
5Joint Venture Manufacturing
TypeOthers
Description

Zydus Sunshine Lifesciences joint venture for pharmaceutical manufacturing plant in Horana, Sri Lanka, targeting Sri Lanka's retail market.

moneycontrol.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D
Pricing details1 tier
1Pharmaceutical products sold through multiple channels with varying price points
ModelOtherBilling cadencePay-as-you-go
Notes

Products distributed through retail pharmacies, hospitals, and government tenders with pricing dependent on channel and contract terms

sunshineholdings.lk
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 6 records shown
1Beclovent
Description

Respiratory pharmaceutical inhaler product manufactured by Lina Manufacturing

sunshineholdings.lk
+5 more records
Core offering1 text field

Sunshine Healthcare Lanka is a fully integrated pharmaceutical company operating across importation, marketing, distribution, manufacturing, and retail of healthcare products in Sri Lanka. The company distributes prescription and OTC pharmaceuticals from 30+ international principals to 4,500+ retailers and hospitals through Healthguard Distribution, manufactures respiratory pharmaceuticals (including the country's only Metered Dose Inhalers) at its WHO-GMP certified Lina Manufacturing facility, distributes medical devices from global manufacturers, and operates a 13-outlet pharmacy retail chain under Healthguard Pharmacy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Increased MDI production capacity from 450,000 to 600,000 canisters per month
+3 more records
Product overview1 text field

Sunshine Healthcare Lanka operates as a fully integrated pharmaceutical company with operations spanning manufacturing, importing, marketing, distribution, and retail. The business portfolio consists of Healthguard Distribution (island-wide pharmaceutical distribution with GDP/ISO 9001:2015 certification serving over 4,500 retailers), Healthguard Pharmacy retail chain (13 outlets in Western Province), Sunshine Medical Devices (surgical and diagnostic equipment distribution), and Lina Manufacturing (WHO-GMP certified pharmaceutical manufacturer producing respiratory products including MDIs, DPI capsules, and inhalers such as Beclovent, Flutivent, Ventohaler). Lina Spiro represents advanced MDI technology for international markets. The company also has a joint venture with Zydus Lifesciences (Zydus Sunshine Lifesciences) for a new pharmaceutical manufacturing facility. Manufacturing operations are supported by the Lina Production System (LPS), a lean Six Sigma framework, while distribution leverages digital tools including iOrder and Project Infinity DaaS model.

Product and service7 records
1Healthguard Distribution
CategoryPharmaceutical Distribution Services
Description

Island-wide pharmaceutical distribution service providing regulatory-compliant distribution of health and wellness products from over 30 international pharmaceutical principals to 4,500+ healthcare retailers and hospitals across Sri Lanka. Operated under GDP and ISO 9001:2015 certifications with cold chain logistics and real-time inventory visibility.

2Healthguard Pharmacy Retail Chain
CategoryRetail Pharmacy Services
Description

Leading health and wellness pharmacy retail chain operating 13 outlets across the Western Province of Sri Lanka, offering pharmaceuticals, medical devices, wellness items, toys, body care, and herbal products to retail consumers.

3Sunshine Medical Devices Distribution
CategoryMedical Devices Distribution
Description

Distribution of surgical, diagnostic, and medical equipment from global manufacturers including Siemens Healthineers, Johnson & Johnson, GE Healthcare, and Coloplast to private hospitals and healthcare facilities across Sri Lanka. Backed by a 426-staff sales, marketing, biomedical engineering, and customer service team.

4Lina Manufacturing Pharmaceutical Production
CategoryPharmaceutical Manufacturing
Description

WHO-GMP certified pharmaceutical manufacturer operating Sri Lanka's only Metered Dose Inhaler (MDI) manufacturing facility, producing respiratory pharmaceuticals and contract development and manufacturing (CDMO) services for international partners. Annual capacity of 600,000 canisters per month after Project 3X expansion.

5Lina Spiro
CategoryPharmaceutical Manufacturing - Advanced Inhalers
Description

Advanced manufacturing venture focused on the latest technology metered-dose inhalers (MDI) for respiratory care. Positioned to enter international markets as the only WHO-GMP certified MDI manufacturer in Sri Lanka.

6CDMO (Contract Development and Manufacturing Organization) Services
CategoryContract Pharmaceutical Manufacturing
Description

Contract pharmaceutical manufacturing services provided through Lina Manufacturing to international partners including Kalbe International, Zydus Cadila, Mankind Pharma, and Truvic Private Limited. CDMO output increased from 3 to 13 registered SKUs in two years with 25 additional SKUs in the regulatory pipeline.

7iOrder Application
CategoryDistribution Digital Tool
Description

Intuitive digital ordering application that simplifies the pharmaceutical ordering process for retail pharmacy and hospital clients of Healthguard Distribution, integrated with the IFS ERP system.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership19 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-06-26
Description

Joint venture Zydus Sunshine Lifesciences formed to establish pharmaceutical manufacturing plant in Horana, Sri Lanka. Total investment exceeding USD 20 million; Zydus investing up to USD 5 million for 50% equity stake. Facility will produce medicines for Sri Lanka's retail market.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-07-01
Description

Truvic launched inhalers manufactured by Lina under the Truvic brand in July 2025. Truvic's new strategy to capture the respiratory market with products manufactured by Lina Manufacturing.

3Micro Healthcare (Pvt) Ltd
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-04-30
Description

Healthguard Distribution entered strategic alliance with Micro Healthcare to distribute Micro Healthcare's comprehensive product offering through Healthguard's extensive island-wide network and logistics expertise.

sunshineholdings.lk
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-02-01
Description

Healthguard Distribution partnered with Breathe Free Lanka to enhance Cipla's portfolio distribution in Sri Lanka.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

CDMO agreement for manufacturing nutraceutical brands (now expanded beyond initial agreement)

Strategic tierCoreTypeStrategic or Co-development Partner
Description

New CDMO contractual agreement with Zydus Cadila for pharmaceutical manufacturing

Strategic tierCoreTypeStrategic or Co-development Partner
Description

New CDMO contractual agreement with Mankind Pharma for pharmaceutical manufacturing

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

International pharmaceutical principal representing diabetes care products in Sri Lanka

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

International pharmaceutical principal representing healthcare products in Sri Lanka

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

International pharmaceutical principal representing dermatology products in Sri Lanka

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

International pharmaceutical principal representing various therapeutic products in Sri Lanka

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Medical devices distribution partner for diagnostic and imaging equipment

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Medical devices distribution partner for surgical products

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Medical devices distribution partner for imaging and monitoring equipment

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Medical devices distribution partner for ostomy and wound care products

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partner for consumer health products through Healthguard Distribution

17Eco Ceylon Global
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partner for wellness products through Healthguard Distribution

sunshineholdings.lk
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partner for health products through Healthguard Distribution

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint venture partner in Watawala Plantations for oil palm and dairy operations. Employs over 1,500 people.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

Indian-headquartered multinational pharmaceutical company with strong respiratory and chronic-disease franchises. Cipla is a principal represented by Sunshine's distribution arm (Breathe Free Lanka partnership) and is a directly relevant emerging-market respiratory peer.

TypeBroad incumbent
Description

Largest pharmaceutical distributor and healthcare services company in North America and Europe. Comparable as a broad incumbent pharma wholesaler whose DaaS-style, GDP-certified, technology-enabled distribution model parallels Healthguard Distribution's value proposition at global scale.

TypeBroad incumbent
Description

Global healthcare major with a sizable established pharmaceuticals and medical devices portfolio that is among Sunshine Healthcare's represented principals. Comparable as a broad incumbent whose products Sunshine distributes and that competes with Sunshine's local manufacturing in some categories.

TypeRegional player
Description

Indian-headquartered generics and specialty pharma company with respiratory, dermatology and cardiovascular franchises that overlap Sunshine's lead therapeutic categories. Glenmark is a principal represented by Sunshine's distribution network in Sri Lanka.

TypeDirect peer
Description

Sri Lankan diversified conglomerate with a significant pharmaceuticals and healthcare distribution arm (Hemas Pharmaceuticals) that imports, markets and distributes a broad portfolio of pharma and consumer health brands. It is the most directly comparable Sri Lankan peer across pharma distribution, manufacturing and consumer health.

TypeRegional player
Description

Global dermatology-focused pharmaceutical company represented by Sunshine in Sri Lanka. Comparable as a multinational principal whose branded dermatology portfolio Sunshine distributes, and whose therapeutic focus overlaps Sunshine's leading dermatology segment.

TypeRegional player
Description

Indian pharmaceutical major and Sunshine's 50:50 JV partner for the new Horana manufacturing plant (USD 20M+ commitment). Comparable integrated pharma manufacturer-distributor model with global CDMO ambitions and similar therapeutic portfolio.

TypeRegional player
Description

One of India's largest pharma companies by domestic market share, focused on affordable generic and OTC medicines. Holds a CDMO agreement with Lina Manufacturing and is comparable as a high-volume, emerging-market-focused pharma operator.

TypeOthers
Description

Global contract logistics provider with dedicated life sciences and healthcare capabilities including GDP-compliant pharma distribution. Comparable as an enabling / adjacent infrastructure provider that validates and competes with the DaaS distribution model Sunshine has pioneered in Sri Lanka.

10CICRA Pharmaceuticals
TypeDirect peer
Description

Sri Lankan pharmaceutical company engaged in manufacturing, importation and distribution of medicines across therapeutic categories. Compares directly to Sunshine's Healthguard Distribution and Lina Manufacturing operations within the same domestic market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance18 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sunshine Healthcare Lanka

Pharmaceutical Distribution and Manufacturingsunshineholdings.lk

Sunshine Healthcare Lanka is the healthcare subsidiary of Sunshine Holdings PLC, operating Sri Lanka's fully integrated pharmaceutical platform spanning manufacturing, importation, distribution, and retail, serving over 4,500 retailers and hospitals as the country's sole domestic MDI producer.

What Sunshine Healthcare Lanka does

Sunshine Healthcare Lanka Limited is the healthcare subsidiary of Sri Lankan conglomerate Sunshine Holdings PLC (Colombo Stock Exchange: SUN.N0000), operating a fully integrated pharmaceutical platform spanning importation, marketing, manufacturing, distribution, and retail. The company operates through four core business units: Healthguard Distribution, which provides island-wide pharmaceutical distribution serving over 4,500 healthcare retailers and hospitals through 7 Regional Distribution Centres covering 150 principal towns and 470 sub-towns; Lina Manufacturing, a WHO-GMP certified pharmaceutical manufacturer producing Sri Lanka's sole domestic Metered Dose Inhalers and related products under brands such as Beclovent, Flutivent, Salbuvent, Ventohaler, and Prazolin; Healthguard Pharmacy, a 13-outlet retail chain concentrated in the Western Province; and Sunshine Medical Devices, which distributes surgical, diagnostic, and imaging equipment from manufacturers including Siemens Healthineers, Johnson & Johnson, and GE Healthcare, supported by a 426-person sales and marketing team.

The technology backbone comprises the Lina Production System (LPS), a customised Lean Six Sigma framework with eight pillars covering quality, digital journey, and HSE; the iOrder application for client ordering; the IFS Enterprise Resource Planning system enabling real-time inventory traceability; and Sri Lanka's first Distribution-as-a-Service (DaaS) model branded as Project Infinity. The company represents more than 30 international pharmaceutical principals including Novo Nordisk, Abbott, Galderma, and Glenmark, and holds a 12% share of Sri Lanka's private pharmaceutical market.

Sunshine Healthcare generates revenue through multi-channel distribution (pharmaceutical distribution, medical devices, retail pharmacy sales, and government tender supply via SPC, Osu Sala, and the Ministry of Health), pharmaceutical manufacturing and contract development & manufacturing (CDMO) services for partners including Zydus Cadila, Mankind Pharma, and Kalbe International, and international pharmaceutical brand representation. The parent group reported LKR 65.9 billion in consolidated FY26 revenue with the Healthcare segment contributing 56.8% (approximately LKR 37.4 billion, ~USD 125 million). The IFC's October 2024 USD 10 million equity investment for a 14.73% stake implies a valuation of approximately USD 68 million for Sunshine Healthcare Lanka, and a 2026 joint venture with Zydus Lifesciences (Zydus Sunshine Lifesciences Pvt. Ltd., a 50:50 arrangement with combined investment exceeding USD 20 million) is adding new manufacturing capacity in Horana, Sri Lanka.

Sunshine Healthcare Lanka firmographics

Firmographics
Name
Sunshine Healthcare Lanka
Legal name
Sunshine Healthcare Lanka Limited
Website
https://sunshineholdings.lk
Company type
Private
Founded year
1967
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Sunshine Healthcare Lanka is the healthcare subsidiary of Sunshine Holdings PLC, operating Sri Lanka's fully integrated pharmaceutical platform spanning manufacturing, importation, distribution, and retail, serving over 4,500 retailers and hospitals as the country's sole domestic MDI producer.
Ownership category
akta.pro rank

Sunshine Healthcare Lanka industry classification

Industry
Product category
Pharmaceutical Distribution and Manufacturing
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmaceutical Preparation Manufacturing (325412)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834), Retail-Drug Stores And Proprietary Stores (5912)
akta.pro primary industry
OTC & Consumer Health Distributors (HLAIAJAC)
akta.pro secondary industries
Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Cold, Flu & Cough Remedies (HLAIADAB), Eye, Ear & Nasal Care (HLAIADAF)

Keywords

  • Pharmaceutical distribution
  • Pharmaceutical manufacturing
  • Retail pharmacy services
  • Medical devices distribution
  • Contract pharmaceutical manufacturing

Where Sunshine Healthcare Lanka is headquartered

Location

Headquarters

HQ city
Colombo
HQ country
Sri Lanka
HQ region
Asia

Offices3 records

Markets served

Sunshine Healthcare Lanka business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

  1. Pharmaceutical Distribution: Distribution of prescription and OTC drugs representing over 50 international pharmaceutical companies. Second-largest private healthcare distribution company in Sri Lanka with 12% market share.
  2. Pharmaceutical Manufacturing: Manufacturing of metered dose inhalers (MDIs) and contract development and manufacturing (CDMO) services. Sole manufacturer of MDIs in Sri Lanka with WHO-GMP certification.
  3. Medical Devices Distribution: Distribution of surgical, diagnostic, and medical equipment from global manufacturers including Siemens Healthineers, Johnson & Johnson, GE Healthcare, and others.
  4. Retail Pharmacy: Healthguard Pharmacies operates 13 retail outlets across Western Province offering pharmaceuticals, medical devices, wellness items, and consumer products.
  5. Joint Venture Manufacturing: Zydus Sunshine Lifesciences joint venture for pharmaceutical manufacturing plant in Horana, Sri Lanka, targeting Sri Lanka's retail market.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goPharmaceutical products sold through multiple channels with varying price points

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Sunshine Healthcare Lanka product offering

Product offering

Core offering

Sunshine Healthcare Lanka is a fully integrated pharmaceutical company operating across importation, marketing, distribution, manufacturing, and retail of healthcare products in Sri Lanka. The company distributes prescription and OTC pharmaceuticals from 30+ international principals to 4,500+ retailers and hospitals through Healthguard Distribution, manufactures respiratory pharmaceuticals (including the country's only Metered Dose Inhalers) at its WHO-GMP certified Lina Manufacturing facility, distributes medical devices from global manufacturers, and operates a 13-outlet pharmacy retail chain under Healthguard Pharmacy.

Product overview

Sunshine Healthcare Lanka operates as a fully integrated pharmaceutical company with operations spanning manufacturing, importing, marketing, distribution, and retail. The business portfolio consists of Healthguard Distribution (island-wide pharmaceutical distribution with GDP/ISO 9001:2015 certification serving over 4,500 retailers), Healthguard Pharmacy retail chain (13 outlets in Western Province), Sunshine Medical Devices (surgical and diagnostic equipment distribution), and Lina Manufacturing (WHO-GMP certified pharmaceutical manufacturer producing respiratory products including MDIs, DPI capsules, and inhalers such as Beclovent, Flutivent, Ventohaler). Lina Spiro represents advanced MDI technology for international markets. The company also has a joint venture with Zydus Lifesciences (Zydus Sunshine Lifesciences) for a new pharmaceutical manufacturing facility. Manufacturing operations are supported by the Lina Production System (LPS), a lean Six Sigma framework, while distribution leverages digital tools including iOrder and Project Infinity DaaS model.

Differentiator

Problem solved

Functional benefit

Brands

  • Beclovent: Respiratory pharmaceutical inhaler product manufactured by Lina Manufacturing
  • Flutivent
  • Salbuvent
  • Prazolin
  • Winterpan
  • Ventohaler

Products and services

  • Healthguard Distribution Island-wide pharmaceutical distribution service providing regulatory-compliant distribution of health and wellness products from over 30 international pharmaceutical principals to 4,500+ healthcare retailers and hospitals across Sri Lanka. Operated under GDP and ISO 9001:2015 certifications with cold chain logistics and real-time inventory visibility.
  • Healthguard Pharmacy Retail Chain Leading health and wellness pharmacy retail chain operating 13 outlets across the Western Province of Sri Lanka, offering pharmaceuticals, medical devices, wellness items, toys, body care, and herbal products to retail consumers.
  • Sunshine Medical Devices Distribution Distribution of surgical, diagnostic, and medical equipment from global manufacturers including Siemens Healthineers, Johnson & Johnson, GE Healthcare, and Coloplast to private hospitals and healthcare facilities across Sri Lanka. Backed by a 426-staff sales, marketing, biomedical engineering, and customer service team.
  • Lina Manufacturing Pharmaceutical Production WHO-GMP certified pharmaceutical manufacturer operating Sri Lanka's only Metered Dose Inhaler (MDI) manufacturing facility, producing respiratory pharmaceuticals and contract development and manufacturing (CDMO) services for international partners. Annual capacity of 600,000 canisters per month after Project 3X expansion.
  • Lina Spiro Advanced manufacturing venture focused on the latest technology metered-dose inhalers (MDI) for respiratory care. Positioned to enter international markets as the only WHO-GMP certified MDI manufacturer in Sri Lanka.
  • CDMO (Contract Development and Manufacturing Organization) Services Contract pharmaceutical manufacturing services provided through Lina Manufacturing to international partners including Kalbe International, Zydus Cadila, Mankind Pharma, and Truvic Private Limited. CDMO output increased from 3 to 13 registered SKUs in two years with 25 additional SKUs in the regulatory pipeline.
  • iOrder Application Intuitive digital ordering application that simplifies the pharmaceutical ordering process for retail pharmacy and hospital clients of Healthguard Distribution, integrated with the IFS ERP system.

Quantifiable outcome

  • Increased MDI production capacity from 450,000 to 600,000 canisters per month
  • +3 more outcomes

Companies that use Sunshine Healthcare Lanka

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Sunshine Healthcare Lanka technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Sunshine Healthcare Lanka partnerships and signals

Strategic signal

Partnerships

19 partnerships are on record, tiered flagship, core and minor.

  • Zydus LifesciencesflagshipStrategic or Co-development Partner · 26 June 2026Joint venture Zydus Sunshine Lifesciences formed to establish pharmaceutical manufacturing plant in Horana, Sri Lanka. Total investment exceeding USD 20 million; Zydus investing up to USD 5 million for 50% equity stake. Facility will produce medicines for Sri Lanka's retail market.
  • Truvic Private LimitedcoreStrategic or Co-development Partner · 1 July 2025Truvic launched inhalers manufactured by Lina under the Truvic brand in July 2025. Truvic's new strategy to capture the respiratory market with products manufactured by Lina Manufacturing.
  • Micro Healthcare (Pvt) LtdcoreChannel Partner/ Reseller/ Distributor · 30 April 2025Healthguard Distribution entered strategic alliance with Micro Healthcare to distribute Micro Healthcare's comprehensive product offering through Healthguard's extensive island-wide network and logistics expertise.
  • Breathe Free LankacoreChannel Partner/ Reseller/ Distributor · 1 February 2025Healthguard Distribution partnered with Breathe Free Lanka to enhance Cipla's portfolio distribution in Sri Lanka.
  • Kalbe InternationalminorStrategic or Co-development PartnerCDMO agreement for manufacturing nutraceutical brands (now expanded beyond initial agreement)
  • Zydus CadilacoreStrategic or Co-development PartnerNew CDMO contractual agreement with Zydus Cadila for pharmaceutical manufacturing
  • Mankind PharmacoreStrategic or Co-development PartnerNew CDMO contractual agreement with Mankind Pharma for pharmaceutical manufacturing
  • Novo NordiskcoreChannel Partner/ Reseller/ DistributorInternational pharmaceutical principal representing diabetes care products in Sri Lanka
  • AbbottcoreChannel Partner/ Reseller/ DistributorInternational pharmaceutical principal representing healthcare products in Sri Lanka
  • GaldermacoreChannel Partner/ Reseller/ DistributorInternational pharmaceutical principal representing dermatology products in Sri Lanka
  • GlenmarkcoreChannel Partner/ Reseller/ DistributorInternational pharmaceutical principal representing various therapeutic products in Sri Lanka
  • Siemens HealthineerscoreChannel Partner/ Reseller/ DistributorMedical devices distribution partner for diagnostic and imaging equipment
  • Johnson & JohnsoncoreChannel Partner/ Reseller/ DistributorMedical devices distribution partner for surgical products
  • GE HealthcarecoreChannel Partner/ Reseller/ DistributorMedical devices distribution partner for imaging and monitoring equipment
  • ColoplastcoreChannel Partner/ Reseller/ DistributorMedical devices distribution partner for ostomy and wound care products
  • AmstedminorChannel Partner/ Reseller/ DistributorDistribution partner for consumer health products through Healthguard Distribution
  • Eco Ceylon GlobalminorChannel Partner/ Reseller/ DistributorDistribution partner for wellness products through Healthguard Distribution
  • Population Services Sri LankaminorChannel Partner/ Reseller/ DistributorDistribution partner for health products through Healthguard Distribution
  • Pyramid Wilmar Plantations Pvt LtdcoreStrategic or Co-development PartnerJoint venture partner in Watawala Plantations for oil palm and dairy operations. Employs over 1,500 people.

Scale indicators13 records

Recent moves7 records

Expansion highlights6 records

Sunshine Healthcare Lanka competitors and assessment

Company assessment

Regional players

  • Cipla: Indian-headquartered multinational pharmaceutical company with strong respiratory and chronic-disease franchises. Cipla is a principal represented by Sunshine's distribution arm (Breathe Free Lanka partnership) and is a directly relevant emerging-market respiratory peer.
  • Glenmark Pharmaceuticals: Indian-headquartered generics and specialty pharma company with respiratory, dermatology and cardiovascular franchises that overlap Sunshine's lead therapeutic categories. Glenmark is a principal represented by Sunshine's distribution network in Sri Lanka.
  • Galderma: Global dermatology-focused pharmaceutical company represented by Sunshine in Sri Lanka. Comparable as a multinational principal whose branded dermatology portfolio Sunshine distributes, and whose therapeutic focus overlaps Sunshine's leading dermatology segment.
  • Zydus Lifesciences: Indian pharmaceutical major and Sunshine's 50:50 JV partner for the new Horana manufacturing plant (USD 20M+ commitment). Comparable integrated pharma manufacturer-distributor model with global CDMO ambitions and similar therapeutic portfolio.
  • Mankind Pharma: One of India's largest pharma companies by domestic market share, focused on affordable generic and OTC medicines. Holds a CDMO agreement with Lina Manufacturing and is comparable as a high-volume, emerging-market-focused pharma operator.

Broad incumbents

  • McKesson: Largest pharmaceutical distributor and healthcare services company in North America and Europe. Comparable as a broad incumbent pharma wholesaler whose DaaS-style, GDP-certified, technology-enabled distribution model parallels Healthguard Distribution's value proposition at global scale.
  • Abbott: Global healthcare major with a sizable established pharmaceuticals and medical devices portfolio that is among Sunshine Healthcare's represented principals. Comparable as a broad incumbent whose products Sunshine distributes and that competes with Sunshine's local manufacturing in some categories.

Direct peers

  • Hemas Holdings: Sri Lankan diversified conglomerate with a significant pharmaceuticals and healthcare distribution arm (Hemas Pharmaceuticals) that imports, markets and distributes a broad portfolio of pharma and consumer health brands. It is the most directly comparable Sri Lankan peer across pharma distribution, manufacturing and consumer health.
  • CICRA Pharmaceuticals: Sri Lankan pharmaceutical company engaged in manufacturing, importation and distribution of medicines across therapeutic categories. Compares directly to Sunshine's Healthguard Distribution and Lina Manufacturing operations within the same domestic market.

Others

  • DHL Supply Chain (Life Sciences & Healthcare): Global contract logistics provider with dedicated life sciences and healthcare capabilities including GDP-compliant pharma distribution. Comparable as an enabling / adjacent infrastructure provider that validates and competes with the DaaS distribution model Sunshine has pioneered in Sri Lanka.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Sunshine Healthcare Lanka social profiles

Digital presence

Sunshine Healthcare Lanka compliance and trust

Trust signal

Compliance18 records

Sunshine Healthcare Lanka financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sunshine Healthcare Lanka leadership team

Management profile

Number of profiles

Profiles3 records

Sunshine Healthcare Lanka subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Sunshine Healthcare Lanka funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sunshine Healthcare Lanka M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sunshine Healthcare Lanka

What does Sunshine Healthcare Lanka do?

Sunshine Healthcare Lanka is a fully integrated pharmaceutical company operating across importation, marketing, distribution, manufacturing, and retail of healthcare products in Sri Lanka. The company distributes prescription and OTC pharmaceuticals from 30+ international principals to 4,500+ retailers and hospitals through Healthguard Distribution, manufactures respiratory pharmaceuticals (including the country's only Metered Dose Inhalers) at its WHO-GMP certified Lina Manufacturing facility, distributes medical devices from global manufacturers, and operates a 13-outlet pharmacy retail chain under Healthguard Pharmacy.

Is Sunshine Healthcare Lanka a public or private company?

Sunshine Healthcare Lanka is a private company. It is classified as corporate owned and is currently operating.

When was Sunshine Healthcare Lanka founded?

Sunshine Healthcare Lanka was founded in 1967. It employs 501 to 1,000 people.

Where is Sunshine Healthcare Lanka based?

Sunshine Healthcare Lanka is headquartered in Colombo, Sri Lanka, in the Asia region.

How does Sunshine Healthcare Lanka make money?

Five revenue lines are on record. Pharmaceutical Distribution is the primary driver. The others are pharmaceutical Manufacturing, medical Devices Distribution, retail Pharmacy and joint Venture Manufacturing.

Who are Sunshine Healthcare Lanka's main competitors?

Regional players on record are Cipla, Glenmark Pharmaceuticals, Galderma, Zydus Lifesciences and Mankind Pharma. Broad incumbents are McKesson and Abbott. Direct peers are Hemas Holdings and CICRA Pharmaceuticals. DHL Supply Chain (Life Sciences & Healthcare) is listed as an others.

Does Sunshine Healthcare Lanka have an API?

No public API is recorded for Sunshine Healthcare Lanka.

What industry is Sunshine Healthcare Lanka in?

Sunshine Healthcare Lanka's product category is Pharmaceutical Distribution and Manufacturing. Its primary akta.pro industry code is HLAIAJAC, OTC & Consumer Health Distributors, with a secondary code of HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant). Its NAICS code is 42421 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
LankatalksSunshine Medical Devices supports Sri Lanka's first national suture championshipSunshine Medical Devices partnered with SLAPRAS to support Sri Lanka's first national suturing championship for undergraduate medical students. The competition brought together students from 11 faculties, with mentorship from leading surgeons. SLAPRAS plans to make it an annual national programme.LankatalksShantha Bandara reappointed SLCPI President as Chamber advances regulatory reform and patient accessShantha Bandara, Director and CEO of Sunshine Healthcare Lanka Ltd., has been reappointed President of the Sri Lanka Chamber of the Pharmaceutical Industry for the 2026/27 term at the Chamber's 65th Annual General Meeting in Colombo. SLCPI members account for over 90% of Sri Lanka's private pharmaceutical market, with the wider industry directly employing more than 80,000 people and indirectly supporting nearly 400,000. Under his renewed mandate, the Chamber will focus on translating institutional reforms—including new Articles of Association and a Code of Conduct—into regulatory and pricing improvements that enhance patient access while ensuring pharmaceutical supplier viability.https://www.outlookbusiness.com/Sunshine Healthcare form JV for pharmaceutical manufacturing in Sri Lanka – Outlook BusinessZydus Lifesciences and Sri Lanka's Sunshine Healthcare Lanka have formed a joint venture, Zydus Sunshine Lifesciences, to establish a pharmaceutical manufacturing facility in the Horana Export Processing Zone with an investment commitment exceeding USD 20 million. Under the agreement, Zydus Lifesciences will subscribe to 50% of the JV's equity for up to USD 5 million, while the facility aims to boost local drug production, reduce import dependence, and improve access to high-quality medicines in Sri Lanka. The JV entity was incorporated on May 30, 2026, with governance structured as six directors—three from each party—and a chairperson appointed by Zydus Lifesciences with casting vote.Business StandardZydus, Sunshine Healthcare form $20-million JV for Sri Lanka pharma plantZydus Lifesciences has formed a joint venture with Sri Lanka's Sunshine Healthcare to build a pharmaceutical manufacturing plant in Horana, Sri Lanka, with an investment exceeding $20 million. The facility, spanning nearly four acres in the Board of Investment zone, will produce medicines for Sri Lanka's retail market and is expected to strengthen the country's healthcare supply-chain resilience while reducing dependence on imports. The venture aligns with Zydus' strategy to expand its international formulations business, which grew nearly 40% year-on-year to Rs 3,070 crore in FY26.BusinessLineZydus Lifesciences, Sunshine Healthcare form $20 million JV to set up pharma manufacturing facility in Sri LankaZydus Lifesciences and Sri Lanka's Sunshine Healthcare have formed a joint venture to establish a pharmaceutical manufacturing facility in Sri Lanka with an investment commitment of over $20 million. The new entity, Zydus Sunshine Lifesciences Pvt Ltd, will develop the plant at the Board of Investment zone in Horana on nearly four acres of land to manufacture pharmaceutical products for Sri Lanka's retail market. The partnership aims to improve access to quality medicines, reduce the country's dependence on pharmaceutical imports, and strengthen Sri Lanka's healthcare ecosystem through technology transfer and local manufacturing capabilities.The HinduZydus, Sunshine Healthcare JV to set up $20 million pharma manufacturing facility in Sri LankaZydus Lifesciences and Sunshine Healthcare Lanka have formed a joint venture to establish a $20 million pharmaceutical manufacturing facility in Sri Lanka, with the foundation stone laid on June 26, 2026 at the Board of Investment zone in Horana. The equal JV, named Zydus Sunshine Lifesciences, will manufacture pharmaceutical products for Sri Lanka's retail market, combining Zydus' global manufacturing expertise with Sunshine's local distribution capabilities. The facility is expected to contribute to Sri Lanka's domestic pharmaceutical production, reduce import dependence, and strengthen the country's healthcare ecosystem.LankatalksZydus Lifesciences and Sunshine Healthcare announce JV to strengthen pharmaceutical manufacturing in Sri LankaZydus Lifesciences and Sunshine Healthcare Lanka have announced a joint venture, Zydus Sunshine Lifesciences Pvt Ltd, to establish a pharmaceutical manufacturing facility in Horana, Sri Lanka, with an investment commitment exceeding USD 20 million. The facility, developed on nearly four acres of land at the Board of Investment zone, will serve Sri Lanka's retail market to improve access to high-quality medicines and reduce the country's dependence on pharmaceutical imports. The partnership combines Zydus' global manufacturing expertise with Sunshine's local market presence, supporting technology transfer, building domestic pharmaceutical capabilities, and contributing to Sri Lanka's healthcare ecosystem development.Financial ExpressZydus Life inks JV with Sri Lanka’s Sunshine Healthcare, to invest up to $5 millionZydus Lifesciences has signed a Share Subscription and Shareholders' Agreement with Sunshine Healthcare Lanka to acquire a 50% stake in the newly incorporated joint venture company Zydus Sunshine Lifesciences, with an investment of up to $5 million. The joint venture plans to establish a state-of-the-art pharmaceutical manufacturing facility in the Horana Export Processing Zone in Sri Lanka to strengthen domestic pharmaceutical production and reduce dependence on imported medicines. Zydus will have equal board representation with Sunshine Healthcare, each nominating three directors, and expects to complete the share subscription within 90 working days.LankatalksSunshine Healthcare Lanka Attracts USD 10 million FDI from IFCSunshine Healthcare Lanka Limited (SHL) completed a USD 10 million equity investment from the International Finance Corporation (IFC), resulting in IFC holding a 14.73% stake in the company. The funds will be used to double pharmaceutical manufacturing capacity for respiratory products and enhance diagnostic capabilities with new medical devices. This transaction is highlighted as a significant foreign direct investment contributing to Sri Lanka's economic resilience.IslandSunshine Healthcare Lanka attracts USD 10 million FDI from IFCSunshine Healthcare Lanka Limited announced the completion of an approximately USD 10 million equity investment from the International Finance Corporation, resulting in IFC holding a 14.73% stake in the company. This foreign direct investment is viewed as a significant milestone for Sri Lanka's economic resilience and will enable Sunshine Healthcare to expand its manufacturing and medical device capabilities.